138 related articles for article (PubMed ID: 10505759)
1. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells.
Kleeff J; Wildi S; Kumbasar A; Friess H; Lander AD; Korc M
Pancreas; 1999 Oct; 19(3):281-8. PubMed ID: 10505759
[TBL] [Abstract][Full Text] [Related]
2. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
Kleeff J; Ishiwata T; Kumbasar A; Friess H; Büchler MW; Lander AD; Korc M
J Clin Invest; 1998 Nov; 102(9):1662-73. PubMed ID: 9802880
[TBL] [Abstract][Full Text] [Related]
3. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
[TBL] [Abstract][Full Text] [Related]
4. Glypican-1 antisense transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic cancer cells.
Li J; Kleeff J; Kayed H; Felix K; Penzel R; Büchler MW; Korc M; Friess H
Biochem Biophys Res Commun; 2004 Aug; 320(4):1148-55. PubMed ID: 15249209
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro degradation of heparan sulfate (HS) proteoglycans by HPR1 in pancreatic adenocarcinomas. Loss of cell surface HS suppresses fibroblast growth factor 2-mediated cell signaling and proliferation.
Xu X; Rao G; Quiros RM; Kim AW; Miao HQ; Brunn GJ; Platt JL; Gattuso P; Prinz RA
J Biol Chem; 2007 Jan; 282(4):2363-73. PubMed ID: 17121850
[TBL] [Abstract][Full Text] [Related]
6. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA.
Aviezer D; Iozzo RV; Noonan DM; Yayon A
Mol Cell Biol; 1997 Apr; 17(4):1938-46. PubMed ID: 9121441
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.
Kornmann M; Arber N; Korc M
J Clin Invest; 1998 Jan; 101(2):344-52. PubMed ID: 9435306
[TBL] [Abstract][Full Text] [Related]
9. Glypican-4 is an FGF2-binding heparan sulfate proteoglycan expressed in neural precursor cells.
Hagihara K; Watanabe K; Chun J; Yamaguchi Y
Dev Dyn; 2000 Nov; 219(3):353-67. PubMed ID: 11066092
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo.
Luo J; Guo P; Matsuda K; Truong N; Lee A; Chun C; Cheng SY; Korc M
Int J Cancer; 2001 May; 92(3):361-9. PubMed ID: 11291072
[TBL] [Abstract][Full Text] [Related]
11. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan.
Marchisone C; Del Grosso F; Masiello L; Prat M; Santi L; Noonan DM
Pathol Oncol Res; 2000; 6(1):10-7. PubMed ID: 10749582
[TBL] [Abstract][Full Text] [Related]
13. Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.
Kayed H; Kleeff J; Keleg S; Jiang X; Penzel R; Giese T; Zentgraf H; Büchler MW; Korc M; Friess H
Int J Oncol; 2006 Nov; 29(5):1139-48. PubMed ID: 17016645
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells. Specific role for glypican-1 in glioma angiogenesis.
Qiao D; Meyer K; Mundhenke C; Drew SA; Friedl A
J Biol Chem; 2003 May; 278(18):16045-53. PubMed ID: 12591930
[TBL] [Abstract][Full Text] [Related]
16. TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo.
Bloomston M; Shafii A; Zervos E; Rosemurgy AS
Am J Surg; 2005 Jun; 189(6):675-9. PubMed ID: 15910719
[TBL] [Abstract][Full Text] [Related]
17. Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.
Ding K; Lopez-Burks M; Sánchez-Duran JA; Korc M; Lander AD
J Cell Biol; 2005 Nov; 171(4):729-38. PubMed ID: 16286510
[TBL] [Abstract][Full Text] [Related]
18. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
Cheng JQ; Ruggeri B; Klein WM; Sonoda G; Altomare DA; Watson DK; Testa JR
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3636-41. PubMed ID: 8622988
[TBL] [Abstract][Full Text] [Related]
19. Effects of glypican-1 on turkey skeletal muscle cell proliferation, differentiation and fibroblast growth factor 2 responsiveness.
Velleman SG; Liu C; Coy CS; McFarland DC
Dev Growth Differ; 2006 May; 48(4):271-6. PubMed ID: 16681652
[TBL] [Abstract][Full Text] [Related]
20. Hsulf-1 regulates growth and invasion of pancreatic cancer cells.
Abiatari I; Kleeff J; Li J; Felix K; Büchler MW; Friess H
J Clin Pathol; 2006 Oct; 59(10):1052-8. PubMed ID: 16603650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
